Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1803
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities ; volume:115 ; number:4 ; day:25 ; month:5 ; year:2020 ; pages:1-15 ; date:7.2020
Basic research in cardiology ; 115, Heft 4 (25.5.2020), 1-15, 7.2020
- Urheber
-
Cuijpers, Ilona
Simmonds, Steven J.
Bilsen, Marc van
Czarnowska, Elżbieta
González Miqueo, Arantxa
Heymans, Stephane
Kuhn, Annika R.
Mulder, Paul
Ratajska, Anna
Jones, Elizabeth A. V.
Brakenhielm, Ebba
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00395-020-0798-y
- URN
-
urn:nbn:de:101:1-2020091521134261581315
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cuijpers, Ilona
- Simmonds, Steven J.
- Bilsen, Marc van
- Czarnowska, Elżbieta
- González Miqueo, Arantxa
- Heymans, Stephane
- Kuhn, Annika R.
- Mulder, Paul
- Ratajska, Anna
- Jones, Elizabeth A. V.
- Brakenhielm, Ebba
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
NASH triggers cardiometabolic HFpEF in aging mice
Different determinants of exercise capacity in HFpEF compared to HFrEF
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry
HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition
Biomarker profiling for risk of future heart failure (HFpEF) development
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
NASH triggers cardiometabolic HFpEF in aging mice
Different determinants of exercise capacity in HFpEF compared to HFrEF
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry
HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition
Biomarker profiling for risk of future heart failure (HFpEF) development
Inflammation in obesity-related HFpEF: the STEP-HFpEF program
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
NASH triggers cardiometabolic HFpEF in aging mice
Different determinants of exercise capacity in HFpEF compared to HFrEF
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry
HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition